Longwood Fund II L.P. 13D and 13G filings for KalVista Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-10 5:11 pm Sale |
2021-02-09 | 13D | KalVista Pharmaceuticals, Inc. KALV |
Longwood Fund II L.P. | 7,801 0.030% |
-926,683 (-99.17%) |
Filing |